MRNA MRNA

Moderna Stock Price

151.68
-6.32 (-4.0%)
Upgrade to Real-Time
Regular Market
151.68
Volume 1,634,925
Bid Price 151.63
Ask Price 151.72
News -
Day High 158.5099

Low
115.61

52 Week Range

High
464.85

Day Low 151.27
Company Name Stock Ticker Symbol Market Type
Moderna Inc MRNA NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-6.32 -4.0% 151.68 10:31:10
Open Price Low Price High Price Close Price Prev Close
157.00 151.27 158.5099 158.00
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
25,632 1,634,925 $ 154.30 $ 252,271,200 - 115.61 - 464.85
Last Trade Time Type Quantity Stock Price Currency
10:31:10 3 $ 151.65 USD

Period:

Draw Mode:

Moderna Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 59.34B 391.20M 290.09M $ 17.74B $ 11.14B 28.29 5.40
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - -979.65k 5.70%

more financials information »

Moderna News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical MRNA Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week174.435180.13150.6628168.434,319,062-22.76-13.04%
1 Month165.36197.44150.6628173.174,504,176-13.68-8.27%
3 Months130.85197.44115.61154.655,134,01620.8315.92%
6 Months147.55197.44115.61152.926,172,0894.132.8%
1 Year406.38464.85115.61254.439,072,706-254.70-62.68%
3 Years13.25497.1713.02152.7912,121,321138.431,044.75%
5 Years22.00497.1711.54149.7010,135,704129.68589.45%

Moderna Description

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 44 mRNA development programs as of early 2022, with 25 of these in clinical trials. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.


Your Recent History
NASDAQ
MRNA
Moderna
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now